Related Experiment Videos
Dyrk1a activates antioxidant NQO1 expression through an ERK1/2-Nrf2 dependent mechanism
Christophe Noll1, Asma Tlili, Clémentine Ripoll
1Univ Paris Diderot-CNRS EAC 4413, Unit of Functional and Adaptive Biology (BFA), Case 7104, 75205 Paris cedex 13, France.
Background And Aims:
Among cardiovascular risk factor, people with Down syndrome have a lower plasma homocysteine level. In a previous study, we have shown that DYRK1A (dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1a), a serine/threonine kinase found on human chromosome 21, is implicated on homocysteine metabolism regulation. Indeed, mice that overexpress in liver this kinase have a lower plasma homocysteine level concomitant with an increased hepatic S-adenosyhomocysteine hydrolase (SAHH) activity, which depends on the activation of NAD(P)H:quinone oxidoreductase-1 (NQO1). Since NQO1 gene transcription is under the control of NRF2 and AhR, the aim of the present study was to analyze the effect of DYRK1A overexpression in mice onto NRF2 and AhR signaling pathways.
Methods:
Effects of DYRK1A overexpression were examined in mice overexpressing Dyrk1a treated with an inhibitor, harmine, by real-time quantitative reverse-transcription polymerase reaction and western blotting.
Results:
We found that overexpression of DYRK1A increases the nuclear NRF2 quantity, concomitant with the activation of ERK1/2. We also show that the overexpression of Dyrk1a has no effect on PI3K/AKT activation, and AhR signaling pathway in liver of mice.
Conclusions:
Our results reveal a link between DYRK1A and NRF2 signaling pathway.
Insights
Overexpression of DYRK1A kinase in mice increases nuclear NRF2 levels, linking DYRK1A to the NRF2 signaling pathway. This kinase influences homocysteine metabolism and cardiovascular risk factors.
Area of Science:
- Biochemistry
- Molecular Biology
- Genetics
Background:
- Down syndrome is associated with lower plasma homocysteine levels.
- DYRK1A (dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1a) is implicated in homocysteine metabolism regulation.
- DYRK1A overexpression in mice lowers plasma homocysteine via increased hepatic S-adenosyhomocysteine hydrolase (SAHH) activity, dependent on NAD(P)H:quinone oxidoreductase-1 (NQO1).
Purpose of the Study:
- To investigate the effect of DYRK1A overexpression on NRF2 and AhR signaling pathways in mice.
- To elucidate the molecular mechanisms linking DYRK1A to homocysteine metabolism.
Main Methods:
- Examined effects of DYRK1A overexpression in mice using real-time quantitative reverse-transcription polymerase reaction and western blotting.
- Analyzed NRF2 and AhR signaling pathway activation in liver tissue.
Main Results:
- DYRK1A overexpression increased nuclear NRF2 quantity and activated ERK1/2 signaling.
- No significant effect of DYRK1A overexpression was observed on PI3K/AKT activation or the AhR signaling pathway in mouse liver.
- Harmine, an inhibitor, was used to study DYRK1A effects.
Conclusions:
- DYRK1A is linked to the NRF2 signaling pathway.
- This study reveals a novel connection between DYRK1A and NRF2 activation, impacting homocysteine metabolism.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Regulation of the Unfolded Protein Response
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
The Unfolded Protein Response